申请人:ADIR, S.A.R.L.
公开号:US04505921A1
公开(公告)日:1985-03-19
New sulfonylurea compounds of the formula: ##STR1## in which n is 1 or 2, R is thienyl, furyl, pyridyl or phenyl optionally mono or disubstituted, R.sub.1 and R.sub.2, the same or different, each are hydrogen, halogen, (C.sub.1 to C.sub.5)-alkyl, (C.sub.1 to C.sub.5)-alkoxy, or trifluoromethyl, or together represent --CH.sub.2 --O--CH.sub.2 --, R.sub.3 is hydrogen, or hydroxy, and R.sub.4 is (C.sub.1 to C.sub.5)-alkyl, (C.sub.3 to C.sub.8)-cycloalkyl or azacycloalkyl of the formula: ##STR2## in which p is zero or an integer from 1 to 5, or azabicycloalkyl of the formula: ##STR3## in which m is 1, 2, or 3. These new compounds and physiologically tolerable salts thereof may be used as medicines especially in the treatment of diabetes.
新的磺酰脲化合物的化学式为:##STR1## 其中n为1或2,R为噻吩基、呋喃基、吡啶基或苯基,可选择性地为单取代或双取代,R.sub.1和R.sub.2,相同或不同,分别为氢、卤素、(C.sub.1到C.sub.5)-烷基、(C.sub.1到C.sub.5)-烷氧基或三氟甲基,或者一起表示--CH.sub.2 --O--CH.sub.2 --,R.sub.3为氢或羟基,R.sub.4为(C.sub.1到C.sub.5)-烷基、(C.sub.3到C.sub.8)-环烷基或化学式为:##STR2## 其中p为零或1到5的整数,或者化学式为:##STR3## 其中m为1、2或3。这些新化合物及其生理耐受盐可用作药物,特别用于糖尿病的治疗。